Symrise AG has signed a minority investment agreement with Bonumose. The early-stage food ingredient manufacturer specializes in the affordable production of delicious, good-for-you rare monosaccharides (alternatives to sucrose) such as...

Dr. Andrew Fordyce, Dr. Katie Whalen, Robert Coward, and Ross Bartels

Internal FDA documents discovered via the Freedom of Information Act indicate a potential FDA bias against health-focused innovation and in favor of industrial corn sweetener producers.

Bonumose was selected for its contributions in the fields of nutrition & health.

ASR Group – exclusive sales and distribution partner – reports strong customer demand for the unique, rare sugar, accelerating the timeline for a second production plant.

Bonumose Inc. to invest $27.7 million, partner with The Hershey Company.

Bonumose is pleased to announce the issuance of U.S. Patent No. 11,078,506 for “Enzymatic Production of D-Allulose”.

Bonumose, Inc., announces the closing of Series B investments co-led by The Hershey Company and American Sugar Refining, Inc.